Heartflow, Inc. (NASDAQ:HTFL) Receives Average Recommendation of “Moderate Buy” from Brokerages

Heartflow, Inc. (NASDAQ:HTFL) has earned a consensus rating of “Moderate Buy” from the eight analysts that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $38.50.

Several brokerages have recently weighed in on HTFL. Stifel Nicolaus upped their price objective on shares of Heartflow from $35.00 to $40.00 and gave the company a “buy” rating in a report on Thursday, November 13th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Heartflow in a research report on Monday, December 29th. Wells Fargo & Company initiated coverage on Heartflow in a report on Wednesday, January 28th. They issued an “overweight” rating and a $38.00 price target on the stock. JPMorgan Chase & Co. raised their price objective on Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Finally, Canaccord Genuity Group upped their target price on Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th.

Heartflow Stock Down 1.4%

Heartflow stock opened at $28.39 on Friday. The firm has a market cap of $2.42 billion and a P/E ratio of -15.69. Heartflow has a 12-month low of $25.38 and a 12-month high of $41.22. The company’s fifty day moving average is $30.59.

Insiders Place Their Bets

In other Heartflow news, Director Jeffrey C. Lightcap acquired 40,000 shares of the stock in a transaction on Tuesday, December 16th. The shares were purchased at an average price of $26.34 per share, for a total transaction of $1,053,600.00. Following the completion of the acquisition, the director owned 40,000 shares in the company, valued at approximately $1,053,600. This represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Institutional Investors Weigh In On Heartflow

Several hedge funds and other institutional investors have recently made changes to their positions in the business. TFC Financial Management Inc. bought a new position in Heartflow in the 3rd quarter valued at about $40,000. Legal & General Group Plc bought a new position in shares of Heartflow in the third quarter valued at approximately $59,000. Strs Ohio purchased a new position in shares of Heartflow during the fourth quarter valued at approximately $99,000. Connable Office Inc. bought a new stake in Heartflow during the fourth quarter worth $220,000. Finally, Y Intercept Hong Kong Ltd purchased a new stake in Heartflow in the 3rd quarter valued at $234,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.